+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Biofabrication Technologies for Tissue and Organ Engineering and Manufacturing. Regenerative and Transplant Medicine

  • Book

  • December 2026
  • Elsevier Science and Technology
  • ID: 6251507
Biofabrication Technologies for Tissue and Organ Engineering and Manufacturing is the fourth volume in the Regenerative and Transplant Medicine Series. The book offers a range of benefits tailored to its diverse audience. For students in biomedical engineering and related fields it provides a comprehensive understanding of biofabrication technologies in tissue and organ engineering and preparing them for future careers. Researchers and scientists in tissue engineering benefit from staying current with the latest advancements, fostering interdisciplinary collaboration, and offering practical insights for experimental design. Clinicians and healthcare professionals gain a deeper understanding of biofabrication applications, improving patient care and staying informed about emerging technologies. Industry professionals in medical devices and biofabrication find valuable insights for product development and market opportunities, while educators use the textbook to enrich curricula and provide real-world applications for students. Regulatory affairs specialists benefit from updates on ethical considerations and compliance in biofabrication, and government officials gain insights into shaping policies for responsible innovation. The authorship is intentionally diverse, encompassing professionals from various backgrounds, including gender, ethnicity, and geographical location. The authors explore applications of biofabrication technologies across different cultural and medical contexts, including voices from underrepresented groups in the fields of biomedical engineering and biofabrication.

Table of Contents

1. Introduction
2. Extrusion-based printing
3. Light-based printing
4. Supporting bath
5. Volumetric printing
6. Multi-nozzle multi-material printing
7. In situ bioprinting
8. 4D printing
9. Bioassembly
10. Bioinks
11. Tissue-specific bioinks
12. Vascular networks
13. Musculoskeletal tissue(s)
14. Heart, cardiac tissue
15. Liver, hepatic tissue
16. Kidney, renal tissue
17. Lung
18. Pancreas
19. Ovary
20. Regulations
21. Industrial perspective, commercialization

Authors

Lorenzo Moroni Professor and Chair, Medicine and Life Sciences, Maastricht University, The Netherlands.

Prof. Lorenzo Moroni studied Biomedical Engineering at Polytechnic University of Milan, Italy, and Nanoscale Sciences at Chalmers Technical University, Sweden. He received his Ph.D. cum laude in 2006 at University of Twente on 3D scaffolds for cartilage and osteochondral regeneration, for which he was awarded the European doctorate award in Biomaterials and Tissue Engineering from the European Society of Biomaterials. His research group interests aim at developing new biofabrication technologies to generate libraries of 3D scaffolds able to control cell fate. This passes through the design of biomaterials, 3D scaffolds, physicochemical, mechanical, and surface properties to better understand cell-material interactions. From 2010-2013, he was a co-founder and scientific advisor of the biotech company Screvo B.V., which is committed to the production of animal implantable 3D high through-put screening systems. He is currently exploring possibilities to start a new spin-off to bring regenerative medicine products for vascular applications to the clinics.

Sang Jin Lee Professor, Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA. Dr. Lee has extensive knowledge and experience in biomaterials science, especially, biodegradable polymers and tunable hydrogels, with specific training and expertise in key research areas for tissue engineering and regenerative medicine. His research team has developed various biomaterial systems that improve cellular interactions by providing appropriate environmental cues. Dr. Lee's research team also demonstrated the principle of "in situ tissue regeneration� that is to take advantage of the body's own regenerating capacity by using the host's ability to mobilize endogenous stem cells to the site of injury. Currently, his research has focused on development of strategies for in situ tissue regeneration in terms of mechanism of host cell recruitment, cell sourcing, cellular and molecular roles in cell differentiation, navigational cues and niche signals, and a tissue-specific smart biomaterial system from the perspective of regenerative medicine and tissue engineering.